Isradipine Capsules and Extended-Release Tablets

14 October 2009

Products Affected - Description

Isradipine, Actavis
2.5 mg capsules, 60 count (NDC 52152-0263-01)
2.5 mg capsules, 100 count (NDC 67767-0108-01) - discontinued
5 mg capsules, 60 count (NDC 52152-0264-01)
5 mg capsules, 100 count (NDC 67767-0109-01) - discontinued

Reason for the Shortage

• GlaxoSmithKline acquired Dynacirc CR from Reliant. The product had been unavailable during this transition.
• Actavis has discontinued isradipine 2.5 mg and 5 mg capsules in 100 count size.

Estimated Resupply Dates

• GlaxoSmithKline has Dynacirc CR 5 mg tablets (NDC 65726-0235-10) and Dynacirc CR 10 mg tablets (NDC 65726-0236-10) available.
• Actavis has isradipine 2.5 mg and 5 mg capsules in 60 count sizes on back order and cannot estimate a release date. The company has no emergency supplies.
• Cobalt has isradipine capsules available in 2.5 mg (100 count, NDC 16252-0539-01) and 5 mg (100 count, NDC 16252-0540-01) strengths.

Related Shortages

• Nicardipine
• Nicardipine Injection— Resolved
• Nimodipine Capsules— Resolved

Updated

October 14, 2009; August 12, 2009; June 16, 2009; April 29, 2009; March 11, 2009; January 30, 2009; December 1, 2008; October 15, 2008; September 26, 2008; September 9, 2008; July 28, 2008; July 16, 2008; June 26, 2008; University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins